MedPath

MKO Melt Dose Pack

Approved
Approval ID

83491310-f848-ce3d-e053-2a91aa0aa906

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 4, 2019

Manufacturers
FDA

Imprimis NJOF, LLC

DUNS: 080431967

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Midazolam - Ketamine HCl - Ondansetron

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71384-410
Product Classification
G
Generic Name
Midazolam - Ketamine HCl - Ondansetron
Product Specifications
Route of AdministrationSUBLINGUAL
Effective DateMarch 4, 2019
FDA Product Classification

INGREDIENTS (3)

MIDAZOLAMActive
Quantity: 3 mg in 1 1
Code: R60L0SM5BC
Classification: ACTIB
KETAMINE HYDROCHLORIDEActive
Quantity: 25 mg in 1 1
Code: O18YUO0I83
Classification: ACTIM
ONDANSETRON HYDROCHLORIDE ANHYDROUSActive
Quantity: 2 mg in 1 1
Code: 2999F27MAD
Classification: ACTIM

Drug Labeling Information

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 3/4/2019

Storage and Handling

Store at 20° to 25° C (68° to 77° F)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MKO Melt Dose Pack - FDA Drug Approval Details